1 |
Flavin adenine dinucleotide
| - | 0件: | - | - | - |
2 |
Formaldehyde
| 1件: Formaldehyde Formaldehyde | 1件: Formalin Formalin; | - | - | 1件: 84 84 |
3 |
Folic acid
| 1件: Folic acid Folic acid | 5件: Acide folique Acide folique; Folate; Folic acid; Multivitamin; NICOTINAMIDE; | - | - | 6件: 6 6, 13, 41, 46, 49, 84 |
4 |
Fibronectin
| - | 0件: | - | - | - |
5 |
Fructose
| - | 0件: | - | - | - |
6 |
Famciclovir
| 1件: Famciclovir Famciclovir | 1件: Famciclovir Famciclovir; | - | - | 1件: 13 13 |
7 |
Famotidine
| 1件: Famotidine Famotidine | 2件: FAMOTIDINA FAMOTIDINA; Famotidine; | 1件: HRH2 HRH2 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | 7件: 6 6, 46, 61, 86, 98, 107, 300 |
8 |
Felodipine
| - | 0件: | - | - | - |
9 |
Fentanyl
| 1件: Fentanyl Fentanyl | 1件: Fentanyl Fentanyl; | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 4件: 46 46, 70, 215, 231 |
10 |
Finasteride
| 1件: Finasteride Finasteride | 1件: Finasteride Finasteride; | 1件: SRD5A2 SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 6 6 |
11 |
Fluconazole
| 1件: Fluconazole Fluconazole | 2件: Diflucan Diflucan; FLUCONAZOLE; | - | - | 2件: 96 96, 225 |
12 |
Flucytosine
| - | 0件: | - | - | - |
13 |
Flunisolide
| - | 0件: | - | - | - |
14 |
Fluocinonide
| - | 0件: | - | - | - |
15 |
Fluoxetine
| 1件: Fluoxetine Fluoxetine | 5件: Fluoxetin Fluoxetin; Fluoxetine; FLUOXETINE HYDROCHLORIDE; Fluoxétine; PROZAC; | 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 6件: 13 13, 17, 78, 86, 179, 206 |
16 |
Fluoxymesterone
| - | 0件: | - | - | - |
17 |
Flurandrenolide
| - | 0件: | - | - | - |
18 |
Flurazepam
| - | 0件: | - | - | - |
19 |
Flurbiprofen
| 1件: Flurbiprofen Flurbiprofen | 1件: FLURBIPROFEN FLURBIPROFEN; | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 3件: 13 13, 21, 46 |
20 |
Furosemide
| 1件: Furosemide Furosemide | 2件: Furosemide Furosemide; Furosemide Injection; | 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 1件: 6 6 |
21 |
Felbamate
| - | 0件: | - | - | - |
22 |
Fenofibrate
| 1件: Fenofibrate Fenofibrate | 1件: Fenofibrate Fenofibrate; | 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 5件: 8 8, 79, 93, 94, 265 |
23 |
Foscarnet sodium
| 1件: Foscarnet Foscarnet | 2件: Foscarnet Foscarnet; Foscarnet sodium; | - | - | 2件: 28 28, 60 |
24 |
Fluorouracil
| - | 0件: | - | - | - |
25 |
Flutamide
| 1件: Flutamide Flutamide | 1件: Flutamide Flutamide; | 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 81 81 |
26 |
Fenoldopam mesylate
| - | 0件: | - | - | - |
27 |
Fosinopril sodium
| - | 0件: | - | - | - |
28 |
Flecainide acetate
| 1件: Flecainide Flecainide | 3件: Flecainide Flecainide; FLECAINIDE ACETATE; Flecainidum; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
29 |
Fexofenadine hydrochloride
| 1件: Fexofenadine Fexofenadine | 1件: Fexofenadine Fexofenadine; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 46 |
30 |
Flurazepam hydrochloride
| - | 0件: | - | - | - |
31 |
Flumazenil
| 1件: Flumazenil Flumazenil | 1件: Flumazenil Flumazenil; | 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 |
32 |
Fomepizole
| 1件: Fomepizole Fomepizole | 1件: 4-Methylpyrazole 4-Methylpyrazole; | 3件: ADH1A ADH1A, ADH1B, ADH1C 💬 | 9件: Alcoholic liver disease Alcoholic liver disease, Drug metabolism - cytochrome P450, Fatty acid degradation, Glycolysis / Gluconeogenesis, Metabolic pathways, Metabolism of xenobiotics by cytochrome P450, Pyruvate metabolism, Retinol metabolism, Tyrosine metabolism 💬 | 1件: 301 301 |
33 |
Flavoxate hydrochloride
| 1件: Flavoxate Flavoxate | 1件: Flavoxate Flavoxate; | 16件: PDE10A PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 18件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
34 |
Fluphenazine hydrochloride
| - | 0件: | - | - | - |
35 |
Fluphenazine enanthate
| - | 0件: | - | - | - |
36 |
Fluphenazine decanoate
| - | 0件: | - | - | - |
37 |
Fluoxetine hydrochloride
| 1件: Fluoxetine Fluoxetine | 5件: Fluoxetin Fluoxetin; Fluoxetine; FLUOXETINE HYDROCHLORIDE; Fluoxétine; PROZAC; | 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 6件: 13 13, 17, 78, 86, 179, 206 |
38 |
Fluvoxamine maleate
| - | 0件: | - | - | - |
39 |
Furazolidone
| - | 0件: | - | - | - |
40 |
Fluvastatin sodium
| 1件: Fluvastatin Fluvastatin | 1件: Fluvastatin Fluvastatin; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 79 79, 218, 222 |
41 |
Fosfomycin tromethamine
| 1件: Fosfomycin Fosfomycin | 1件: Fosfomycin Fosfomycin; | - | - | 4件: 63 63, 96, 97, 222 |
42 |
Fenoprofen calcium
| - | 0件: | - | - | - |
43 |
Fludrocortisone acetate
| 1件: Fludrocortisone Fludrocortisone | 1件: Fludrocortisone Fludrocortisone; | 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 3件: 6 6, 17, 81 |
44 |
Flupentixol
| 1件: Flupentixol Flupentixol | 1件: Flupentixol Flupentixol; | 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 97 97 |
45 |
Furazabol
| - | 0件: | - | - | - |
46 |
Fulvestrant
| 1件: Fulvestrant Fulvestrant | 2件: Faslodex Faslodex; Fulvestrant; | 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 2件: 49 49, 86 |
47 |
Ferrous fumarate
| - | 0件: | - | - | - |
48 |
Febuxostat
| 1件: Febuxostat Febuxostat | 1件: Febuxostat Febuxostat; | 1件: XDH XDH 💬 | 5件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | 3件: 2 2, 6, 13 |
49 |
Flunitrazepam
| - | 0件: | - | - | - |
50 |
Flucloxacillin sodium
| 1件: Flucloxacillin Flucloxacillin | 1件: FLUCLOXACILLIN FLUCLOXACILLIN; | - | - | 1件: 299 299 |
51 |
Fluorescein
| 1件: Fluorescein Fluorescein | 1件: Fluorescein Fluorescein; | - | - | 3件: 19 19, 22, 97 |
52 |
Floctafenine
| - | 0件: | - | - | - |
53 |
Flunarizine hydrochloride
| 1件: Flunarizine Flunarizine | 0件: | 3件: CACNA1G CACNA1G, CACNA1H, CACNA1I 💬 | 8件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬 | 4件: 58 58, 86, 149, 215 |
54 |
Feprazone
| - | 0件: | - | - | - |
55 |
Fenbufen
| - | 0件: | - | - | - |
56 |
Fludiazepam
| - | 0件: | - | - | - |
57 |
Fluorometholone
| - | 0件: | - | - | - |
58 |
Formoterol fumarate
| 1件: Formoterol Formoterol | 2件: Formoterol Formoterol; Symbicort; | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 85 85, 228, 299 |
59 |
Fentanyl citrate
| 1件: Fentanyl Fentanyl | 1件: Fentanyl Fentanyl; | 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 4件: 46 46, 70, 215, 231 |
60 |
Flurazepam hydrochloride
| - | 0件: | - | - | - |
61 |
Fosfluconazole
| 1件: Fluconazole Fluconazole | 2件: Diflucan Diflucan; FLUCONAZOLE; | - | - | 2件: 96 96, 225 |
62 |
Flumethasone pivalate
| - | 0件: | - | - | - |
63 |
Flurbiprofen axetil
| 1件: Flurbiprofen Flurbiprofen | 1件: FLURBIPROFEN FLURBIPROFEN; | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 3件: 13 13, 21, 46 |
64 |
Flufenamic acid
| - | 0件: | - | - | - |
65 |
Ferric ammonium citrate
| - | 0件: | - | - | - |
66 |
Felbinac
| - | 0件: | - | - | - |
67 |
Fluticasone propionate
| 1件: Fluticasone propionate Fluticasone propionate | 3件: Flovent Flovent; Fluticasone; FLUTICASONE PROPIONATE; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 98 98, 228 |
68 |
Fleroxacin
| - | 0件: | - | - | - |
69 |
Fluocinolone acetonide
| 1件: Fluocinolone acetonide Fluocinolone acetonide | 2件: Fluocinolone Acetonide Fluocinolone Acetonide; Iluvien; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 |
70 |
Fidarestat
| - | 0件: | - | - | - |
71 |
Fludeoxyglucose F 18
| 1件: Fludeoxyglucose Fludeoxyglucose | 1件: Fludeoxyglucose Fludeoxyglucose; | - | - | 4件: 34 34, 84, 85, 88 |
72 |
Fondaparinux sodium
| - | 0件: | - | - | - |
73 |
Fludarabine phosphate
| 1件: Fludarabine Fludarabine | 4件: FLUDARA FLUDARA; FLUDARABINA; Fludarabine; Fludarabine Phosphate; | 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 19件: 13 13, 19, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
74 |
Fentiazac
| - | 0件: | - | - | - |
75 |
Fluorescein sodium
| 1件: Fluorescein Fluorescein | 1件: Fluorescein Fluorescein; | - | - | 3件: 19 19, 22, 97 |
76 |
Fluphenazine maleate
| - | 0件: | - | - | - |
77 |
Fosfomycin calcium hydrate
| 1件: Fosfomycin Fosfomycin | 1件: Fosfomycin Fosfomycin; | - | - | 4件: 63 63, 96, 97, 222 |
78 |
Fosfomycin sodium
| 1件: Fosfomycin Fosfomycin | 1件: Fosfomycin Fosfomycin; | - | - | 4件: 63 63, 96, 97, 222 |
79 |
Foscarnet sodium hydrate
| 1件: Foscarnet Foscarnet | 2件: Foscarnet Foscarnet; Foscarnet sodium; | - | - | 2件: 28 28, 60 |
80 |
Flurbiprofen sodium
| 1件: Flurbiprofen Flurbiprofen | 1件: FLURBIPROFEN FLURBIPROFEN; | 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 3件: 13 13, 21, 46 |
81 |
Flumequine
| - | 0件: | - | - | - |
82 |
Fumaric acid
| 1件: Fumaric acid Fumaric acid | 1件: Fumaric acid Fumaric acid; | - | - | 2件: 13 13, 49 |
83 |
Fenoprofen
| - | 0件: | - | - | - |
84 |
Ferrous gluconate
| - | 0件: | - | - | - |
85 |
Fosamprenavir
| - | 0件: | - | - | - |
86 |
Furaltadone
| - | 0件: | - | - | - |
87 |
Flibanserin
| - | 0件: | - | - | - |
88 |
Fenticonazole
| - | 0件: | - | - | - |
89 |
Fluanisone
| - | 0件: | - | - | - |
90 |
Fluspirilene
| - | 0件: | - | - | - |
91 |
Filgrastim
| 1件: Filgrastim Filgrastim | 7件: Filgrastim Filgrastim; Filgrastim Hexal; G-CSF; Granulocyte Colony Stimulating Factor; Neupogen; TEVAGRASTIM; Zarzio; | 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 34件: 2 2, 6, 11, 13, 16, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
92 |
Flufenamate aluminum
| - | 0件: | - | - | - |
93 |
Fursultiamine
| - | 0件: | - | - | - |
94 |
Firocoxib
| - | 0件: | - | - | - |
95 |
Fosinoprilat
| - | 0件: | - | - | - |
96 |
Ferumoxides
| - | 0件: | - | - | - |
97 |
Factor IX complex
| - | 0件: | - | - | - |
98 |
Farampator
| - | 0件: | - | - | - |
99 |
Febantel
| - | 0件: | - | - | - |
100 |
Felypressin
| - | 0件: | - | - | - |
101 |
Fenamole
| 1件: Fenamole Fenamole | 0件: | - | - | 3件: 6 6, 13, 160 |
102 |
Fenbendazole
| - | 0件: | - | - | - |
103 |
Fenobam
| - | 0件: | - | - | - |
104 |
Fenoterol
| - | 0件: | - | - | - |
105 |
Fenprostalene
| - | 0件: | - | - | - |
106 |
Fenquizone
| - | 0件: | - | - | - |
107 |
Fenretinide
| 1件: Fenretinide Fenretinide | 1件: Fenretinide Fenretinide; | 2件: RARA RARA, RARB 💬 | 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 299 299 |
108 |
Ferric oxide
| 1件: Ferric oxide Ferric oxide | 1件: Iron oxide Iron oxide; | - | - | 1件: 13 13 |
109 |
Ferumoxsil
| - | 0件: | - | - | - |
110 |
Ferumoxytol
| 1件: Ferumoxytol Ferumoxytol | 2件: Feraheme Feraheme; Ferumoxytol; | - | - | 1件: 13 13 |
111 |
Fiacitabine
| - | 0件: | - | - | - |
112 |
Fialuridine
| - | 0件: | - | - | - |
113 |
Filaminast
| - | 0件: | - | - | - |
114 |
Florfenicol
| - | 0件: | - | - | - |
115 |
Flosequinan
| - | 0件: | - | - | - |
116 |
Floxacillin
| 1件: Flucloxacillin Flucloxacillin | 1件: FLUCLOXACILLIN FLUCLOXACILLIN; | - | - | 1件: 299 299 |
117 |
Floxuridine
| - | 0件: | - | - | - |
118 |
Flubendazole
| - | 0件: | - | - | - |
119 |
Flucloronide
| - | 0件: | - | - | - |
120 |
Flumethasone
| - | 0件: | - | - | - |
121 |
Flunisolide acetate
| - | 0件: | - | - | - |
122 |
Flunixin
| - | 0件: | - | - | - |
123 |
Fluocortolone
| - | 0件: | - | - | - |
124 |
Fluocortolone caproate
| - | 0件: | - | - | - |
125 |
Fluorometholone acetate
| - | 0件: | - | - | - |
126 |
Fluprednisolone
| - | 0件: | - | - | - |
127 |
Flurothyl
| - | 0件: | - | - | - |
128 |
Fontolizumab
| 1件: Fontolizumab Fontolizumab | 1件: Fontolizumab Fontolizumab; | 1件: IFNG IFNG 💬 | 32件: African trypanosomiasis African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 46 46 |
129 |
Forasartan
| - | 0件: | - | - | - |
130 |
Formocortal
| - | 0件: | - | - | - |
131 |
Fosfomycin
| 1件: Fosfomycin Fosfomycin | 1件: Fosfomycin Fosfomycin; | - | - | 4件: 63 63, 96, 97, 222 |
132 |
Fosfonet sodium
| - | 0件: | - | - | - |
133 |
Frovatriptan succinate
| - | 0件: | - | - | - |
134 |
Furaprofen
| - | 0件: | - | - | - |
135 |
Fusidic acid
| 1件: Fusidic acid Fusidic acid | 2件: Fucidin Fucidin; FUSIDIC ACID; | - | - | 1件: 299 299 |
136 |
Follitropin alfa
| - | 0件: | - | - | - |
137 |
Follitropin beta
| - | 0件: | - | - | - |
138 |
Framycetin
| - | 0件: | - | - | - |
139 |
Formoterol fumarate hydrate
| 1件: Formoterol Formoterol | 2件: Formoterol Formoterol; Symbicort; | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 85 85, 228, 299 |
140 |
Fluticasone furoate
| - | 0件: | - | - | - |
141 |
Firategrast
| 1件: Firategrast Firategrast | 1件: Firategrast Firategrast; | 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
142 |
Forodesine
| - | 0件: | - | - | - |
143 |
Fennel
| - | 0件: | - | - | - |
144 |
Fenpiprane
| - | 0件: | - | - | - |
145 |
Fenoverine
| - | 0件: | - | - | - |
146 |
Fendiline
| - | 0件: | - | - | - |
147 |
Flutrimazole
| - | 0件: | - | - | - |
148 |
Fluprednidene
| - | 0件: | - | - | - |
149 |
Flunoxaprofen
| - | 0件: | - | - | - |
150 |
Fesoterodine
| 1件: Fesoterodine Fesoterodine | 1件: Fesoterodine Fesoterodine; | 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
151 |
Flurithromycin
| - | 0件: | - | - | - |
152 |
Fotemustine
| - | 0件: | - | - | - |
153 |
Formestane
| - | 0件: | - | - | - |
154 |
Fazadinium bromide
| - | 0件: | - | - | - |
155 |
Febarbamate
| - | 0件: | - | - | - |
156 |
Flumedroxone
| - | 0件: | - | - | - |
157 |
Fencamfamin
| - | 0件: | - | - | - |
158 |
Fenozolone
| - | 0件: | - | - | - |
159 |
Fipexide
| - | 0件: | - | - | - |
160 |
Fenoxazoline
| - | 0件: | - | - | - |
161 |
Fedrilate
| - | 0件: | - | - | - |
162 |
Fibrinolysin
| - | 0件: | - | - | - |
163 |
Fasudil
| 1件: Fasudil Fasudil | 1件: Fasudil Fasudil; | 2件: ROCK1 ROCK1, ROCK2 💬 | 23件: Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 5, 7, 51 |
164 |
Fenetylline
| - | 0件: | - | - | - |
165 |
Fenfluramine
| 1件: Fenfluramine Fenfluramine | 2件: Fenfluramina Fenfluramina; FENFLURAMINE; | 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 140 140, 144, 145, 149 |
166 |
Fenoldopam
| - | 0件: | - | - | - |
167 |
Fenproporex
| - | 0件: | - | - | - |
168 |
Fenspiride
| - | 0件: | - | - | - |
169 |
Fenthion
| - | 0件: | - | - | - |
170 |
Fenyramidol
| - | 0件: | - | - | - |
171 |
Fepradinol
| - | 0件: | - | - | - |
172 |
Fexofenadine
| 1件: Fexofenadine Fexofenadine | 1件: Fexofenadine Fexofenadine; | 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 46 |
173 |
Flavoxate
| 1件: Flavoxate Flavoxate | 1件: Flavoxate Flavoxate; | 16件: PDE10A PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 18件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
174 |
Flecainide
| 1件: Flecainide Flecainide | 3件: Flecainide Flecainide; FLECAINIDE ACETATE; Flecainidum; | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
175 |
Flomoxef
| - | 0件: | - | - | - |
176 |
Fluazuron
| - | 0件: | - | - | - |
177 |
Flucloxacillin sodium salt
| 1件: Flucloxacillin Flucloxacillin | 1件: FLUCLOXACILLIN FLUCLOXACILLIN; | - | - | 1件: 299 299 |
178 |
Fludarabine
| 1件: Fludarabine Fludarabine | 4件: FLUDARA FLUDARA; FLUDARABINA; Fludarabine; Fludarabine phosphate; | 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 19件: 13 13, 19, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
179 |
Fludrocortisone
| 1件: Fludrocortisone Fludrocortisone | 1件: Fludrocortisone Fludrocortisone; | 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 3件: 6 6, 17, 81 |
180 |
Fluindione
| - | 0件: | - | - | - |
181 |
Flunarizine
| 1件: Flunarizine Flunarizine | 0件: | 3件: CACNA1G CACNA1G, CACNA1H, CACNA1I 💬 | 8件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬 | 4件: 58 58, 86, 149, 215 |
182 |
Fluocortin
| - | 0件: | - | - | - |
183 |
Fluocortolone 21-pivalate
| - | 0件: | - | - | - |
184 |
Fluorouracil sodium salt
| - | 0件: | - | - | - |
185 |
Fluphenazine
| - | 0件: | - | - | - |
186 |
Flupirtine
| 1件: Flupirtine Flupirtine | 1件: Flupirtine Flupirtine; | - | - | 1件: 13 13 |
187 |
Fluprednidene acetate
| - | 0件: | - | - | - |
188 |
Fluticasone
| 1件: Fluticasone Fluticasone | 1件: Fluticasone Fluticasone; | 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 98 98, 228, 299 |
189 |
Fluvastatin
| 1件: Fluvastatin Fluvastatin | 1件: Fluvastatin Fluvastatin; | 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 79 79, 218, 222 |
190 |
Fluvoxamine
| - | 0件: | - | - | - |
191 |
Folinic acid
| 1件: Leucovorin Leucovorin | 2件: Folinic acid Folinic acid; Leucovorin; | - | - | 4件: 19 19, 46, 107, 320 |
192 |
Folinic acid calcium salt pentahydrate
| 1件: Leucovorin Leucovorin | 2件: Folinic acid Folinic acid; Leucovorin; | - | - | 4件: 19 19, 46, 107, 320 |
193 |
Fominoben
| - | 0件: | - | - | - |
194 |
Fomivirsen
| - | 0件: | - | - | - |
195 |
Formoterol
| 1件: Formoterol Formoterol | 2件: Formoterol Formoterol; Symbicort; | 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 85 85, 228, 299 |
196 |
Fosinopril
| - | 0件: | - | - | - |
197 |
Fosphenytoin
| - | 0件: | - | - | - |
198 |
Frovatriptan
| - | 0件: | - | - | - |
199 |
Furazidin
| - | 0件: | - | - | - |
200 |
Fusafungine
| - | 0件: | - | - | - |
201 |
Ferrous succinate
| - | 0件: | - | - | - |
202 |
Faropenem medoxomil
| - | 0件: | - | - | - |
203 |
Ferric carboxymaltose
| 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose Ferric carboxymaltose; | - | - | 4件: 86 86, 96, 97, 299 |
204 |
Ferric subsulfate
| - | 0件: | - | - | - |
205 |
Ferric sulfate
| 1件: Ferric sulfate Ferric sulfate | 1件: Stasis Stasis; | - | - | 2件: 66 66, 97 |
206 |
Farletuzumab
| - | 0件: | - | - | - |
207 |
Figitumumab
| - | 0件: | - | - | - |
208 |
Fostamatinib
| 1件: Fostamatinib Fostamatinib | 1件: Fostamatinib Fostamatinib; | 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 4件: 46 46, 49, 61, 66 |
209 |
Fidaxomicin
| - | 0件: | - | - | - |
210 |
Favipiravir
| - | 0件: | - | - | - |
211 |
Fezakinumab
| - | 0件: | - | - | - |
212 |
Filibuvir
| - | 0件: | - | - | - |
213 |
Foretinib
| - | 0件: | - | - | - |
214 |
Fresolimumab
| 1件: Fresolimumab Fresolimumab | 2件: Fresolimumab Fresolimumab; GC1008; | 3件: TGFB1 TGFB1, TGFB2, TGFB3 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 4件: 51 51, 85, 222, 274 |
215 |
Forigerimod
| 1件: Forigerimod Forigerimod | 1件: Forigerimod Forigerimod; | - | - | 1件: 49 49 |
216 |
Fosdevirine
| - | 0件: | - | - | - |
217 |
Fulranumab
| - | 0件: | - | - | - |
218 |
Fingolimod
| 1件: Fingolimod Fingolimod | 2件: FINGOLIMOD FINGOLIMOD; GILENYA; | 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 14, 156 |
219 |
Fispemifene
| - | 0件: | - | - | - |
220 |
Fiboflapon
| - | 0件: | - | - | - |
221 |
Ficlatuzumab
| - | 0件: | - | - | - |
222 |
Fasiglifam
| - | 0件: | - | - | - |
223 |
Fasinumab
| - | 0件: | - | - | - |
224 |
Filorexant
| - | 0件: | - | - | - |
225 |
Fluralaner
| - | 0件: | - | - | - |
226 |
Firtecan pegol
| - | 0件: | - | - | - |
227 |
Fimasartan
| - | 0件: | - | - | - |
228 |
Fabomotizole
| - | 0件: | - | - | - |
229 |
Finafloxacin
| - | 0件: | - | - | - |
230 |
Fedratinib
| - | 0件: | - | - | - |
231 |
Fevipiprant
| - | 0件: | - | - | - |
232 |
Filociclovir
| - | 0件: | - | - | - |
233 |
Finerenone
| - | 0件: | - | - | - |
234 |
Fosdagrocorat
| - | 0件: | - | - | - |
235 |
Fostemsavir
| - | 0件: | - | - | - |
236 |
Ferric maltol
| 1件: Ferric maltol Ferric maltol | 1件: Ferric Maltol Ferric Maltol; | - | - | 1件: 96 96 |
237 |
Fluciclovine F-18
| - | 0件: | - | - | - |
238 |
Filgotinib
| 1件: Filgotinib Filgotinib | 2件: FILGOTINIB FILGOTINIB; Jyseleca; | 1件: JAK1 JAK1 💬 | 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 6件: 46 46, 53, 96, 97, 222, 271 |
239 |
Fonadelpar
| - | 0件: | - | - | - |
240 |
Fosaprepitant
| - | 0件: | - | - | - |
241 |
Ferric pyrophosphate citrate
| 1件: Ferric pyrophosphate citrate Ferric pyrophosphate citrate | 0件: | - | - | 1件: 13 13 |
242 |
Fremanezumab
| 1件: Fremanezumab Fremanezumab | 1件: Fremanezumab Fremanezumab; | 1件: CALCA CALCA 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 2件: 124 124, 226 |
243 |
Fosnetupitant
| - | 0件: | - | - | - |
244 |
Funapide
| - | 0件: | - | - | - |
245 |
Flortaucipir F 18
| 1件: Flortaucipir Flortaucipir | 1件: Flortaucipir Flortaucipir; | 1件: MAPT MAPT 💬 | 4件: Alzheimer disease Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 5 5, 7, 127 |
246 |
Fexinidazole
| 1件: Fexinidazole Fexinidazole | 1件: Fexinidazole Fexinidazole; | - | - | 1件: 65 65 |
247 |
Fluorocholine F-18
| - | 0件: | - | - | - |
248 |
Flotetuzumab
| - | 0件: | - | - | - |
249 |
Frovocimab
| - | 0件: | - | - | - |
250 |
Fenebrutinib
| 1件: Fenebrutinib Fenebrutinib | 1件: FENEBRUTINIB FENEBRUTINIB; | 1件: BTK BTK 💬 | 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 1件: 13 13 |
251 |
Faricimab
| - | 0件: | - | - | - |
252 |
Fenofibric acid
| - | 0件: | - | - | - |
253 |
Foslinanib
| - | 0件: | - | - | - |
254 |
Firsocostat
| - | 0件: | - | - | - |
255 |
Fosmanogepix
| - | 0件: | - | - | - |
256 |
Futibatinib
| - | 0件: | - | - | - |
257 |
Fisogatinib
| - | 0件: | - | - | - |
258 |
Filanesib
| - | 0件: | - | - | - |
259 |
Fletikumab
| 1件: Fletikumab Fletikumab | 1件: Anti-IL-20 Anti-IL-20; | 1件: IL20 IL20 💬 | 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
260 |
Fosdenopterin
| - | 0件: | - | - | - |
261 |
Ferric derisomaltose
| - | 0件: | - | - | - |
262 |
Foslevodopa
| 1件: Foslevodopa Foslevodopa | 1件: Foslevodopa Foslevodopa; | 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
263 |
Fezolinetant
| - | 0件: | - | - | - |
264 |
Fruquintinib
| - | 0件: | - | - | - |
265 |
Feladilimab
| - | 0件: | - | - | - |
266 |
Foscarbidopa
| 1件: Foscarbidopa Foscarbidopa | 1件: Foscarbidopa Foscarbidopa; | - | - | 1件: 6 6 |
267 |
Felcisetrag
| - | 0件: | - | - | - |